Tosk drug TK-90 successful in preventing painful, dose-limiting mucositis caused by common cancer therapies.

MOUNTAIN VIEW, CALIFORNIA, USA, December 17, 2018 /⁨EINPresswire.com⁩/ — Privately held biotechnology company, Tosk, Inc., announced …
Tosk Announces Clinical Study Results for TK-90 to Prevent Mucositis